3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Glioblastoma
2
Breast Neoplasms
2
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Astrocytoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Lenalidomide
11
Cyclophosphamide
11
Rituximab
10
Prednisone
8
Magnetic Resonance Spectroscopy
7
obinutuzumab
6
Vincristine
6
Doxorubicin
6
Specimen Handling
5
Biopsy
5
Bendamustine Hydrochloride
5
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Radiotherapy
3
R-CHOP protocol
3
Cyclosporine
3
zanubrutinib
2
tazemetostat
2
pembrolizumab
2
ibrutinib
2
Temozolomide
2
Prednisolone
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Melphalan
2
Gemcitabine
2
Etoposide
2
Dexamethasone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
veliparib
×
30 days
×
Clear all
No trials found.